Capela Renata Campos, Corrente José Eduardo, Magalhães Claudia Saad
Universidade Estadual Paulista Júlio de Mesquita Filho, Botucatu, SP, Brasil.
Universidade Estadual Paulista Júlio de Mesquita Filho, Botucatu, SP, Brasil.
Rev Bras Reumatol. 2015 Jan-Feb;55(1):31-6. doi: 10.1016/j.rbr.2014.08.010. Epub 2014 Oct 24.
the assessment of the activity of rheumatoid arthritis and juvenile idiopathic arthritis is made by means of different tools, respectively DAS-28 and JADAS.
To compare DAS-28 and JADAS with scores of 71, 27 and 10 joint counts in juvenile idiopathic arthritis.
A secondary analysis of a phase III placebo-controlled trial, testing safety and efficacy of abatacept was conducted in 8 patients with 178 assessment visits. Joint count scores for active and limited joints, physician's and parents' global assessment by 0-10cm Visual Analog Scale, and erythrocyte sedimentation rate normalized to 0-10 scale, in all visits. The comparison among the activity indices in different observations was made through Anova or adjusted gamma model. The paired observations between DAS-28 and JADAS 71, 27 and 10, respectively, were analyzed by linear regression.
There were significant differences among individual measures, except for ESR, in the first four months of biological treatment, when five of the eight patients reached ACR-Pedi 30, with improvement. The indices of DAS-28, JADAS 71, 27 and 10 also showed significant difference during follow-up. Linear regression adjusted model between DAS-28 and JADAS resulted in mathematical formulas for conversion: [DAS-28=0.0709 (JADAS 71)+1.267] (R(2)=0.49); [DAS-28=0.084 (JADAS 27) +1.7404] (R(2)=0.47) and [DAS-28=0.1129 (JADAS-10) +1.5748] (R(2)=0.50).
The conversion of scores of DAS-28 and JADAS 71, 27 and 10 for this mathematical model would allow equivalent application of both in adolescents with arthritis.
类风湿性关节炎和青少年特发性关节炎的活动度评估分别通过不同工具进行,即DAS-28和JADAS。
比较青少年特发性关节炎中关节计数分别为71、27和10时的DAS-28和JADAS评分。
对一项评估阿巴西普安全性和疗效的III期安慰剂对照试验进行二次分析,该试验纳入了8例患者,共进行了178次评估访视。在所有访视中记录活动关节和受限关节的关节计数评分、医生和家长采用0-10厘米视觉模拟量表进行的整体评估,以及标准化为0-10量表的红细胞沉降率。通过方差分析或调整后的伽马模型对不同观察中的活动指数进行比较。分别对DAS-28与JADAS 71、27和10之间的配对观察进行线性回归分析。
在生物治疗的前四个月,除红细胞沉降率外,各项指标之间存在显著差异,8例患者中有5例病情改善,达到美国儿科学会(ACR)儿科30标准。在随访期间,DAS-28、JADAS 71、27和10指数也显示出显著差异。DAS-28与JADAS之间的线性回归调整模型得出了转换的数学公式:[DAS-28 = 0.0709(JADAS 71)+ 1.267](R² = 0.49);[DAS-28 = 0.084(JADAS 27)+ 1.7404](R² = 0.47);以及[DAS-28 = 0.1129(JADAS - 10)+ 1.5748](R² = 0.50)。
该数学模型对DAS-28和JADAS 71、27和10评分的转换,将使二者在青少年关节炎患者中得以等效应用。